Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinician
University of Debrecen · Manchester Academic Health Science Centre · +11 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
122
total citations
- FWCI
- 49.40
- Percentile
- 100%
- References
- 120
Citations per year
Authors
9- ZSZoltán SzekaneczCorresponding
University of Debrecen
- MHMaya H Buch
Manchester Academic Health Science Centre, University of Manchester, NIHR Manchester Biomedical Research Centre
- CCChristina Charles‐Schoeman
University of California, Los Angeles, Los Angeles Medical Center
- JGJames Galloway
King's College London
- GKGeorge Karpouzas
University of California, Los Angeles, Los Angeles Medical Center
Topics & keywords
Topics
Keywords
- Tofacitinib
- Medicine
- Rheumatoid arthritis
- Janus kinase
- Janus kinase inhibitor
- Internal medicine
- Clinical trial
- Adverse effect
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.